NO20013145L - Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden - Google Patents
Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetidenInfo
- Publication number
- NO20013145L NO20013145L NO20013145A NO20013145A NO20013145L NO 20013145 L NO20013145 L NO 20013145L NO 20013145 A NO20013145 A NO 20013145A NO 20013145 A NO20013145 A NO 20013145A NO 20013145 L NO20013145 L NO 20013145L
- Authority
- NO
- Norway
- Prior art keywords
- inhibitors
- drug
- prevention
- preparation
- sodium hydrogen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19859727A DE19859727A1 (de) | 1998-12-23 | 1998-12-23 | Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung |
PCT/EP1999/009621 WO2000038661A2 (de) | 1998-12-23 | 1999-12-08 | Die verwendung von hemmern des natrium-wasserstoff-austauschers zur herstellung eines medikaments zur verhinderung von altersbedingten organ-dysfunktionen, altersbedingten erkrankungen und zur lebensverlängerung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20013145D0 NO20013145D0 (no) | 2001-06-22 |
NO20013145L true NO20013145L (no) | 2001-08-22 |
Family
ID=7892436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013145A NO20013145L (no) | 1998-12-23 | 2001-06-22 | Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden |
Country Status (20)
Country | Link |
---|---|
US (1) | US6420430B1 (cs) |
EP (1) | EP1140056A2 (cs) |
JP (1) | JP2002533386A (cs) |
KR (1) | KR20010086152A (cs) |
CN (1) | CN1367689A (cs) |
AR (1) | AR021965A1 (cs) |
AU (1) | AU776761B2 (cs) |
BR (1) | BR9916505A (cs) |
CA (1) | CA2357837A1 (cs) |
CZ (1) | CZ20012309A3 (cs) |
DE (1) | DE19859727A1 (cs) |
HR (1) | HRPK20010470B1 (cs) |
HU (1) | HUP0104652A3 (cs) |
IL (1) | IL143372A0 (cs) |
NO (1) | NO20013145L (cs) |
RU (1) | RU2238721C2 (cs) |
SK (1) | SK9042001A3 (cs) |
TR (1) | TR200101803T2 (cs) |
WO (1) | WO2000038661A2 (cs) |
ZA (1) | ZA200104301B (cs) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003244430A1 (en) * | 2002-02-04 | 2003-09-02 | Sanofi-Aventis Deutschland Gmbh | Combination preparation of the sodium-hydrogen exchange inhibitor cariporide with ace inhibitors for preventing heart failure and other age-related dysfunctions of organs, age- related diseases and for prolonging lifespan |
US6844361B2 (en) * | 2002-02-04 | 2005-01-18 | Aventis Pharma Deutschland Gmbh | Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
US7375138B2 (en) * | 2002-05-18 | 2008-05-20 | Sanofi-Aventis Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, processes for their preparation, their use as medicaments or diagnostic aids, and medicaments comprising them |
FR2840302B1 (fr) * | 2002-06-03 | 2004-07-16 | Aventis Pharma Sa | Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
US6878748B2 (en) | 2002-06-13 | 2005-04-12 | Aventis Pharma Deutschland Gmbh | Fluorinated cycloalkyl-derivatized benzoylguanidines, process for their preparation, their uses as medicament, and medicament containing them |
NZ544671A (en) * | 2003-06-26 | 2009-02-28 | Biotron Ltd | Antiviral compounds and methods |
US8017863B2 (en) * | 2005-11-02 | 2011-09-13 | The Regents Of The University Of Michigan | Polymer wrapped carbon nanotube near-infrared photoactive devices |
US7947897B2 (en) * | 2005-11-02 | 2011-05-24 | The Trustees Of Princeton University | Organic photovoltaic cells utilizing ultrathin sensitizing layer |
US8013240B2 (en) * | 2005-11-02 | 2011-09-06 | The Trustees Of Princeton University | Organic photovoltaic cells utilizing ultrathin sensitizing layer |
KR101042078B1 (ko) * | 2009-01-13 | 2011-06-16 | 한국항공우주산업 주식회사 | 치공구 제작용 수평 측면 가공 치구 |
CN104103253B (zh) | 2014-07-04 | 2016-08-17 | 京东方科技集团股份有限公司 | 发射电极扫描电路、阵列基板和显示装置 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE147375T1 (de) * | 1992-09-22 | 1997-01-15 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, sowie ihre verwendung als antiarrhythmika |
ES2152938T3 (es) * | 1992-09-28 | 2001-02-16 | Hoechst Ag | 1(2h)-isoquinolinas sustituidas antiarritmicas y cardioprotectoras, procedimiento para su produccion, medicamento que las contiene y su uso para la produccion de un medicamento para combatir fallos cardiacos. |
SE508028C2 (sv) * | 1993-05-12 | 1998-08-10 | Moelnlycke Ab | Midjebälte för absorberande plagg |
DE4328352A1 (de) | 1993-08-24 | 1995-03-02 | Hoechst Ag | Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE69501219T2 (de) | 1994-02-25 | 1998-04-16 | Microtecnica | Elektrolyt-aktivierte Batterie |
DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
DE19502644A1 (de) | 1995-01-28 | 1996-08-01 | Merck Patent Gmbh | 4-Amino-benzoylguanidin-Derivate |
DE19502895A1 (de) * | 1995-01-31 | 1996-08-01 | Merck Patent Gmbh | 4-Mercapto-benzoylguanidin-Derivate |
EP0738712B1 (en) * | 1995-04-18 | 1999-08-18 | Hoechst Aktiengesellschaft | Anti-arrhythmic and cardioprotective substituted indenoylguanidines |
EP0765867A1 (de) * | 1995-09-27 | 1997-04-02 | Hoechst Aktiengesellschaft | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Antiarrhytmika oder Diagnostikum sowie sie enthaltendes Medikament |
DE19542306A1 (de) * | 1995-11-14 | 1997-05-15 | Hoechst Ag | Sulfonylamino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19621319A1 (de) | 1996-05-28 | 1997-12-04 | Hoechst Ag | Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19622222A1 (de) * | 1996-06-03 | 1997-12-04 | Hoechst Ag | Verwendung von Inhibitoren des zellulären Na·+·/H·+·-Exchangers (NHE) zur Herstellung eines Medikament zur Normalisierung der Serumlipide |
JP2002502414A (ja) * | 1997-06-02 | 2002-01-22 | 藤沢薬品工業株式会社 | 細胞中のNa▲上+▼/H▲上+▼交換の阻害剤としてのグアニジン誘導体 |
DE19734693A1 (de) * | 1997-08-11 | 1998-01-22 | Hoechst Marion Roussel De Gmbh | Verwendung von Cariporide als Inhibitor des zellulären NA+/H+-Exchangers (NHE) zur Herstellung eines Medikaments zur Behandlung von cardialen und nichtcardialen Krankheiten |
US6011059A (en) * | 1997-12-24 | 2000-01-04 | Bristol-Myers Squibb Company | Acyl guanidine sodium/proton exchange inhibitors and method |
CA2260499A1 (en) * | 1998-01-29 | 1999-07-29 | Sumitomo Pharmaceuticals Company Limited | Pharmaceutical compositions for the treatment of ischemic brain damage |
-
1998
- 1998-12-23 DE DE19859727A patent/DE19859727A1/de not_active Withdrawn
-
1999
- 1999-12-08 RU RU2001120358A patent/RU2238721C2/ru not_active IP Right Cessation
- 1999-12-08 AU AU16576/00A patent/AU776761B2/en not_active Ceased
- 1999-12-08 HU HU0104652A patent/HUP0104652A3/hu unknown
- 1999-12-08 CA CA002357837A patent/CA2357837A1/en not_active Abandoned
- 1999-12-08 BR BR9916505-8A patent/BR9916505A/pt not_active IP Right Cessation
- 1999-12-08 JP JP2000590615A patent/JP2002533386A/ja not_active Withdrawn
- 1999-12-08 TR TR2001/01803T patent/TR200101803T2/xx unknown
- 1999-12-08 CN CN99815044A patent/CN1367689A/zh active Pending
- 1999-12-08 EP EP99959387A patent/EP1140056A2/de not_active Ceased
- 1999-12-08 KR KR1020017008052A patent/KR20010086152A/ko not_active Application Discontinuation
- 1999-12-08 CZ CZ20012309A patent/CZ20012309A3/cs unknown
- 1999-12-08 WO PCT/EP1999/009621 patent/WO2000038661A2/de not_active Application Discontinuation
- 1999-12-08 IL IL14337299A patent/IL143372A0/xx unknown
- 1999-12-08 SK SK904-2001A patent/SK9042001A3/sk unknown
- 1999-12-21 AR ARP990106639A patent/AR021965A1/es unknown
- 1999-12-22 US US09/469,299 patent/US6420430B1/en not_active Expired - Fee Related
-
2001
- 2001-05-25 ZA ZA200104301A patent/ZA200104301B/xx unknown
- 2001-06-20 HR HR20010470A patent/HRPK20010470B1/xx not_active IP Right Cessation
- 2001-06-22 NO NO20013145A patent/NO20013145L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TR200101803T2 (tr) | 2001-10-22 |
NO20013145D0 (no) | 2001-06-22 |
US6420430B1 (en) | 2002-07-16 |
HRP20010470A2 (en) | 2002-06-30 |
CA2357837A1 (en) | 2000-07-06 |
CN1367689A (zh) | 2002-09-04 |
BR9916505A (pt) | 2001-11-20 |
RU2238721C2 (ru) | 2004-10-27 |
AU1657600A (en) | 2000-07-31 |
CZ20012309A3 (cs) | 2001-09-12 |
ZA200104301B (en) | 2003-02-20 |
DE19859727A1 (de) | 2000-06-29 |
SK9042001A3 (en) | 2001-12-03 |
AR021965A1 (es) | 2002-09-04 |
AU776761B2 (en) | 2004-09-23 |
EP1140056A2 (de) | 2001-10-10 |
HUP0104652A2 (hu) | 2002-03-28 |
HRPK20010470B1 (en) | 2003-10-31 |
IL143372A0 (en) | 2002-04-21 |
RU2001120358A (ru) | 2005-12-10 |
KR20010086152A (ko) | 2001-09-08 |
WO2000038661A3 (de) | 2000-11-09 |
WO2000038661A2 (de) | 2000-07-06 |
JP2002533386A (ja) | 2002-10-08 |
HUP0104652A3 (en) | 2002-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145907A0 (en) | Use of glucosylceramide synthesis inhibitors in therapy | |
GB0013378D0 (en) | Use of therapeutic benzamide derivatives | |
CO4970819A1 (es) | Tratamiento de disfuncion sexual femenina en una hembra humana | |
NO20014560D0 (no) | Quinasoliner og terapautisk anvendelse derav | |
NO20013145L (no) | Anvendelse av inhibitorer av natriumhydrogenutbytteren for fremstilling av et medikament for prevensjon av organdysfunksjonerog -sykdommer relatert en spesiell alder og for a forlengelevetiden | |
PL345776A1 (en) | Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases | |
NO983926L (no) | Farmas°ytisk kombinasjonspreparat av en inhibitor av natrium-hydrogen-veksler og et legemiddel for behandling av hjertekretsl°p-sykdommer | |
SE9700934D0 (sv) | New formulation | |
HK1077215A1 (en) | A pharmaceutical composition for treatment of acute myocardial infarction | |
ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
HK1026637A1 (en) | Compositions for administering taxanes orally to human patients and their use | |
ITMI20001051A0 (it) | Formulazioni contenenti un farmaco glucocorticosteroide per il trattamento di patologie broncopolmonari | |
BR0308795A (pt) | Amidas do ácido sulfamico | |
ITRM990719A0 (it) | Uso di ubichinone q10 per il trattamento locale e la prevenzione di patalogie aftalmologiche secondarie alla terapia fotorefrattiva, chirurg | |
AU2001274344A1 (en) | Tissue inhibitors of matrix metalloproteinases | |
NO20006349L (no) | Hydroksamsyrederivater som inhibitorer for produksjon av humant CD23 og av TNF-frigjöring | |
AU2001282551A1 (en) | Heart muscular cell apoptosis inhibitors and remedies/preventives for heart diseases | |
TW200509945A (en) | Agent for treatment of anal disease | |
EE200200227A (et) | Tüüp 1 naatrium-vesinik ioniidi inhibiitori kristallid | |
CA2304899A1 (en) | New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease | |
ID26666A (id) | Penggunaan agen untuk pencegahan penyakit gusi | |
NO20004679D0 (no) | Farmasøytisk sammensetning inneholdende en cystein- proteasehemmer for forebygging og terapi av hjernevevsforringelse | |
GB9828845D0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
GB9927780D0 (en) | The therapeutic use of matrix metalloproteinase inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |